183 related articles for article (PubMed ID: 33239003)
41. Ginsenoside Rg3 ameliorates acute exacerbation of COPD by suppressing neutrophil migration.
Guan X; Yuan Y; Wang G; Zheng R; Zhang J; Dong B; Ran N; Hsu AC; Wang C; Wang F
Int Immunopharmacol; 2020 Jun; 83():106449. PubMed ID: 32278128
[TBL] [Abstract][Full Text] [Related]
42. [Comprehension and recognition of acute exacerbation among chronic obstructive pulmonary disease patients].
Jiang M; Ma JF
Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Oct; 34(10):1030-4. PubMed ID: 24378002
[TBL] [Abstract][Full Text] [Related]
43. IL-22 Defect During Streptococcus pneumoniae Infection Triggers Exacerbation of Chronic Obstructive Pulmonary Disease.
Pichavant M; Sharan R; Le Rouzic O; Olivier C; Hennegrave F; Rémy G; Pérez-Cruz M; Koné B; Gosset P; Just N; Gosset P
EBioMedicine; 2015 Nov; 2(11):1686-96. PubMed ID: 26870795
[TBL] [Abstract][Full Text] [Related]
44. Butyrate inhibits iILC2-mediated lung inflammation via lung-gut axis in chronic obstructive pulmonary disease (COPD).
Jiang M; Li Z; Zhang F; Li Z; Xu D; Jing J; Li F; Wang J; Ding J
BMC Pulm Med; 2023 May; 23(1):163. PubMed ID: 37173731
[TBL] [Abstract][Full Text] [Related]
45. Cigarette smoke-induced autophagy impairment accelerates lung aging, COPD-emphysema exacerbations and pathogenesis.
Vij N; Chandramani-Shivalingappa P; Van Westphal C; Hole R; Bodas M
Am J Physiol Cell Physiol; 2018 Jan; 314(1):C73-C87. PubMed ID: 27413169
[TBL] [Abstract][Full Text] [Related]
46. Connective Tissue Growth Factor Promotes Pulmonary Epithelial Cell Senescence and Is Associated with COPD Severity.
Jang JH; Chand HS; Bruse S; Doyle-Eisele M; Royer C; McDonald J; Qualls C; Klingelhutz AJ; Lin Y; Mallampalli R; Tesfaigzi Y; Nyunoya T
COPD; 2017 Apr; 14(2):228-237. PubMed ID: 28026993
[TBL] [Abstract][Full Text] [Related]
47. General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trial.
Bates J; Francis NA; White P; Gillespie D; Thomas-Jones E; Breen R; Kirby N; Hood K; Gal M; Phillips R; Naik G; Cals J; Llor C; Melbye H; Wootton M; Riga E; Cochrane A; Howe R; Fitzsimmons D; Sewell B; Alam MF; Butler CC
Trials; 2017 Sep; 18(1):442. PubMed ID: 28969667
[TBL] [Abstract][Full Text] [Related]
48. Novel biomarker genes which distinguish between smokers and chronic obstructive pulmonary disease patients with machine learning approach.
Matsumura K; Ito S
BMC Pulm Med; 2020 Feb; 20(1):29. PubMed ID: 32013930
[TBL] [Abstract][Full Text] [Related]
49. Acute Exacerbation of a Chronic Obstructive Pulmonary Disease Prediction System Using Wearable Device Data, Machine Learning, and Deep Learning: Development and Cohort Study.
Wu CT; Li GH; Huang CT; Cheng YC; Chen CH; Chien JY; Kuo PH; Kuo LC; Lai F
JMIR Mhealth Uhealth; 2021 May; 9(5):e22591. PubMed ID: 33955840
[TBL] [Abstract][Full Text] [Related]
50. An Integrative Transcriptomic and Metabolomic Study Revealed That Melatonin Plays a Protective Role in Chronic Lung Inflammation by Reducing Necroptosis.
Mao K; Luo P; Geng W; Xu J; Liao Y; Zhong H; Ma P; Tan Q; Xia H; Duan L; Song S; Long D; Liu Y; Yang T; Wu Y; Jin Y
Front Immunol; 2021; 12():668002. PubMed ID: 34017341
[TBL] [Abstract][Full Text] [Related]
51. Patient characteristics associated with risk of first hospital admission and readmission for acute exacerbation of chronic obstructive pulmonary disease (COPD) following primary care COPD diagnosis: a cohort study using linked electronic patient records.
Hunter LC; Lee RJ; Butcher I; Weir CJ; Fischbacher CM; McAllister D; Wild SH; Hewitt N; Hardie RM
BMJ Open; 2016 Jan; 6(1):e009121. PubMed ID: 26801463
[TBL] [Abstract][Full Text] [Related]
52. Protocols to Evaluate Cigarette Smoke-Induced Lung Inflammation and Pathology in Mice.
Vlahos R; Bozinovski S
Methods Mol Biol; 2018; 1725():53-63. PubMed ID: 29322408
[TBL] [Abstract][Full Text] [Related]
53. A Novel Metabolic Score for Predicting the Acute Exacerbation in Patients with Chronic Obstructive Pulmonary Disease.
Peng L; You H; Xu MY; Dong ZY; Liu M; Jin WJ; Zhou C
Int J Chron Obstruct Pulmon Dis; 2023; 18():785-795. PubMed ID: 37180750
[TBL] [Abstract][Full Text] [Related]
54. Phenotyping COPD exacerbations using imaging and blood-based biomarkers.
Alotaibi NM; Chen V; Hollander Z; Hague CJ; Murphy DT; Leipsic JA; DeMarco ML; FitzGerald JM; McManus BM; Ng RT; Sin DD
Int J Chron Obstruct Pulmon Dis; 2018; 13():217-229. PubMed ID: 29386890
[TBL] [Abstract][Full Text] [Related]
55. Plasma sCD146 is a potential biomarker for acute exacerbation of chronic obstructive pulmonary disease.
Jia X; Jiang J; Yang C; Zhang S; Wu J; Ma Q; Wang Z; Chen Z; Zhang M; Huang M; Ji N
Clin Transl Sci; 2024 Mar; 17(3):e13754. PubMed ID: 38476031
[TBL] [Abstract][Full Text] [Related]
56. [Correlative factors analysis and predictive model construction of intestinal flora imbalance during acute exacerbation of chronic obstructive pulmonary disease].
Zeng XT; Ma XQ; Gu XN; Deng SM; Zhu TF
Zhonghua Yi Xue Za Zhi; 2020 Nov; 100(40):3174-3178. PubMed ID: 33142402
[No Abstract] [Full Text] [Related]
57. Correlation of Serum Clara Cell Secretory Protein 16, Plasma Fibrinogen and Serum Amyloid A with the Severity of Acute Exacerbated COPD and Their Combination in Prognosis Assessment.
Hu X; Xu J; Li P; Zheng H
Int J Chron Obstruct Pulmon Dis; 2023; 18():1949-1957. PubMed ID: 37700931
[TBL] [Abstract][Full Text] [Related]
58. A Systematic Review of Diagnostic Biomarkers of COPD Exacerbation.
Chen YW; Leung JM; Sin DD
PLoS One; 2016; 11(7):e0158843. PubMed ID: 27434033
[TBL] [Abstract][Full Text] [Related]
59. IL-17A and the Promotion of Neutrophilia in Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Roos AB; Sethi S; Nikota J; Wrona CT; Dorrington MG; Sandén C; Bauer CM; Shen P; Bowdish D; Stevenson CS; Erjefält JS; Stampfli MR
Am J Respir Crit Care Med; 2015 Aug; 192(4):428-37. PubMed ID: 26039632
[TBL] [Abstract][Full Text] [Related]
60. [Construction and verification of the risk prediction model for acute exacerbation within 6 months in patients with chronic obstructive pulmonary disease: a secondary analysis based on previous research data].
Wang M; Cai K; Shi D; Bi L; Li J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Apr; 34(4):373-377. PubMed ID: 35692201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
